Adicet Bio (ACET) Competitors $0.99 -0.05 (-4.81%) Closing price 10/17/2025 04:00 PM EasternExtended Trading$0.98 -0.01 (-0.51%) As of 10/17/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ACET vs. ADMA, URI, FAST, GWW, WSO, WCC, AIT, AL, GATX, and MSMShould you be buying Adicet Bio stock or one of its competitors? The main competitors of Adicet Bio include ADMA Biologics (ADMA), United Rentals (URI), Fastenal (FAST), W.W. Grainger (GWW), Watsco (WSO), WESCO International (WCC), Applied Industrial Technologies (AIT), Air Lease (AL), GATX (GATX), and MSC Industrial Direct (MSM). Adicet Bio vs. Its Competitors ADMA Biologics United Rentals Fastenal W.W. Grainger Watsco WESCO International Applied Industrial Technologies Air Lease GATX MSC Industrial Direct Adicet Bio (NASDAQ:ACET) and ADMA Biologics (NASDAQ:ADMA) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, analyst recommendations, media sentiment, earnings, risk, dividends, profitability and institutional ownership. Do insiders & institutionals hold more shares of ACET or ADMA? 83.9% of Adicet Bio shares are owned by institutional investors. Comparatively, 75.7% of ADMA Biologics shares are owned by institutional investors. 7.8% of Adicet Bio shares are owned by insiders. Comparatively, 3.5% of ADMA Biologics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has preferable earnings and valuation, ACET or ADMA? ADMA Biologics has higher revenue and earnings than Adicet Bio. Adicet Bio is trading at a lower price-to-earnings ratio than ADMA Biologics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAdicet Bio$24.99M3.30-$117.12M-$1.31-0.76ADMA Biologics$426.45M8.04$197.67M$0.8616.70 Does the media prefer ACET or ADMA? In the previous week, ADMA Biologics had 2 more articles in the media than Adicet Bio. MarketBeat recorded 5 mentions for ADMA Biologics and 3 mentions for Adicet Bio. ADMA Biologics' average media sentiment score of 0.87 beat Adicet Bio's score of 0.52 indicating that ADMA Biologics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Adicet Bio 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive ADMA Biologics 4 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk & volatility, ACET or ADMA? Adicet Bio has a beta of 1.62, meaning that its share price is 62% more volatile than the S&P 500. Comparatively, ADMA Biologics has a beta of 0.47, meaning that its share price is 53% less volatile than the S&P 500. Do analysts recommend ACET or ADMA? Adicet Bio currently has a consensus price target of $5.67, suggesting a potential upside of 472.39%. ADMA Biologics has a consensus price target of $27.67, suggesting a potential upside of 92.66%. Given Adicet Bio's higher probable upside, analysts plainly believe Adicet Bio is more favorable than ADMA Biologics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Adicet Bio 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 2.83ADMA Biologics 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.25 Is ACET or ADMA more profitable? ADMA Biologics has a net margin of 44.06% compared to Adicet Bio's net margin of 0.00%. ADMA Biologics' return on equity of 41.01% beat Adicet Bio's return on equity.Company Net Margins Return on Equity Return on Assets Adicet BioN/A -68.48% -57.84% ADMA Biologics 44.06%41.01%28.47% SummaryADMA Biologics beats Adicet Bio on 12 of the 17 factors compared between the two stocks. Get Adicet Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ACET and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ACET and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACET vs. The Competition Export to ExcelMetricAdicet BioMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$86.58M$3.40B$6.10B$10.50BDividend YieldN/A2.28%5.73%4.81%P/E Ratio-0.7622.4484.5227.09Price / Sales3.30429.40586.66210.72Price / CashN/A46.5937.1661.22Price / Book0.4410.4112.246.52Net Income-$117.12M-$52.47M$3.32B$276.75M7 Day Performance2.36%2.32%1.25%2.00%1 Month Performance22.16%11.14%6.28%2.26%1 Year Performance-31.72%11.15%59.92%35.58% Adicet Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACETAdicet Bio2.5783 of 5 stars$0.99-4.8%$5.67+472.4%-33.1%$86.58M$24.99M-0.7690News CoverageADMAADMA Biologics3.6303 of 5 stars$14.55+0.1%$27.67+90.1%-10.9%$3.47B$426.45M16.92530URIUnited Rentals4.2799 of 5 stars$974.44+2.6%$956.13-1.9%+16.6%$61.13B$15.35B25.2027,900Positive NewsUpcoming EarningsFASTFastenal4.5218 of 5 stars$42.33-7.5%$47.41+12.0%+9.4%$52.54B$7.55B40.7023,702Trending NewsEarnings ReportDividend AnnouncementAnalyst ForecastAnalyst RevisionHigh Trading VolumeGWWW.W. Grainger4.4266 of 5 stars$935.80-1.2%$1,073.88+14.8%-14.6%$45.32B$17.17B23.7526,000Positive NewsAnalyst ForecastWSOWatsco4.4709 of 5 stars$365.27-0.5%$472.50+29.4%-26.4%$14.88B$7.62B28.017,295Trending NewsAnalyst ForecastAnalyst RevisionWCCWESCO International4.0193 of 5 stars$213.08+2.3%$235.20+10.4%+18.0%$10.14B$21.82B16.6920,000News CoverageAnalyst ForecastAITApplied Industrial Technologies4.7373 of 5 stars$247.09+0.4%$285.00+15.3%+5.4%$9.29B$4.56B24.426,800News CoveragePositive NewsAnalyst RevisionALAir Lease4.8256 of 5 stars$63.53+0.1%$60.29-5.1%+41.5%$7.10B$2.73B7.71150Short Interest ↓GATXGATX2.5919 of 5 stars$170.87+1.0%$183.50+7.4%+28.2%$6.02B$1.59B19.552,150Upcoming EarningsMSMMSC Industrial Direct3.4354 of 5 stars$85.91+0.3%$90.33+5.2%+2.1%$4.77B$3.82B24.277,423News CoverageUpcoming EarningsAnalyst Forecast Related Companies and Tools Related Companies ADMA Alternatives URI Alternatives FAST Alternatives GWW Alternatives WSO Alternatives WCC Alternatives AIT Alternatives AL Alternatives GATX Alternatives MSM Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ACET) was last updated on 10/18/2025 by MarketBeat.com Staff From Our PartnersBuy alert: Move $1,000 before Tesla’s Optimus launchElon's $1,000,000,000,000 payday Elon Musk just made his biggest insider purchase of Tesla stock ever. He's...Altimetry | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredTrump Devises the Death of the IRS ☠️Trump has just signed an executive order creating America's first-ever National Investment Fund — a game-chang...Angel Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adicet Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adicet Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ACET Stock Alerts